Literature DB >> 9258561

Prevalence of hepatitis C virus infection in Nanjing, southern China.

K Suzuki1, M Mizokami, K Cao, X S Wu, R R Wu, A Hata, M Sasaki, Z X Fang, L Y Zhang, J Y Lau, S Iino.   

Abstract

There is little information on the prevalence of hepatitis C virus (HCV) infection in China. The prevalence of HCV infection was determined in 998 subjects (398 with liver disease and 600 without) in the city of Nanjing in southern China. Subjects were tested for anti-HCV antibodies by a second generation assay. We also determined serological HCV genotypes and HCV RNA sequences. Among the 600 subjects without liver disease, 3 (0.5%) were seroreactive for anti-HCV. All were less than 12 years of age and had a history of transfusion. Of the 398 liver disease patients, 20 (5.0%) were seroreactive for anti-HCV. Of 16 patients in whom serological HCV genotype was determined, 10 (62.5%) were infected with HCV type 1, 5 (31.3%) with type 2 and 1 (6.3%) undetermined. HCV genomes sequenced from 2 patients belonged to genotype 2 and were closely related to strains in Beijing and Japan by molecular evolutionary analysis. These results suggest that HCV infection is rare and not a major cause of liver disease in southern China.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258561     DOI: 10.1023/a:1007320118967

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  25 in total

1.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

Authors:  H Okamoto; S Okada; Y Sugiyama; K Kurai; H Iizuka; A Machida; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

2.  Seroepidemiology of HCV and HBV infection in northern China.

Authors:  Q M Tao; Y Wang; H Wang; W R Chen; Y Sun; Q Meng; J Watanabe; K Nishioka
Journal:  Gastroenterol Jpn       Date:  1991-07

3.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

4.  Sequence analysis of putative structural regions of hepatitis C virus isolated from 5 Japanese patients with hepatocellular carcinoma.

Authors:  M Honda; S Kaneko; M Unoura; K Kobayashi; S Murakami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Estimation of average number of nucleotide substitutions when the rate of substitution varies with nucleotide.

Authors:  T Gojobori; K Ishii; M Nei
Journal:  J Mol Evol       Date:  1982       Impact factor: 2.395

6.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Improved detection of antibodies to hepatitis C virus using a second generation ELISA.

Authors:  S Lee; J McHutchinson; B Francis; R DiNello; A Polito; S Quan; M Nelles
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

9.  The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA.

Authors:  P J Chen; M H Lin; K F Tai; P C Liu; C J Lin; D S Chen
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

10.  Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals.

Authors:  T Tanaka; N Kato; M Nakagawa; Y Ootsuyama; M J Cho; T Nakazawa; M Hijikata; Y Ishimura; K Shimotohno
Journal:  Virus Res       Date:  1992-04       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.